Newsletter Subscription

Enter Name and Email

News

NeuroAct Communication advances its consulting assignments, scientific communication and online presence.
You can keep up to date with latest news by regularly checking announcements on this page.

To receive occasional Newsletters by email, enter your contact details.
To view previous Newsletters click here.

 

Title Filter 

1 26 January 2015 - Adrian gives invited lecture at Bristol University
2 12 January 2015 - Neurolixis announces drug discovery collaboration with Krakow University
3 17 October 2014 - Adrian to chair session and present at World Orphan Drug Congress
4 22 September 2014 - Adrian takes on role at French subsidiary of Neurolixis
5 08 August 2014 - Adrian is Principal Investigator of a new grant from the MJFF
6 31 July 2014 - Just published: regulation of 5-HT1A receptors in Alzheimer disease brain
7 12 June 2014 - Adrian to chair session and present at neuroscience webinar
8 10 June 2014 - Just published: autonomic dysfunction in Rett syndrome: role of 5-HT1A agonists.
9 11 April 2014 - Adrian is co-Principal Investigator of a grant from the Int. Rett Syndrome Foundation
10 02 April 2014 - Just published: comparison of antipsychotics in rat models of BPSD
11 25 March 2014 - Adrian is Principal Investigator of a new research grant from the MJFF to Neurolixis
12 04 March 2014 - European Commission approves Orphan Medicinal Product designation for NLX-101
13 13 February 2014 - Just published: Commentary on antipsychotics with potential neuroprotective action
14 24 January 2014 - Just published: review of serotonin 5-HT1A effects in depression and anxiety
15 23 January 2014 - Just published: pharmacology of a novel drug for BPSD: ADN-1184
16 13 December 2013 - Adrian to present at Pharmacology 2013 meeting in London
17 12 December 2013 - PhD Examination board at brain imaging center in Lyon
18 05 November 2011 - Brainstorming Session on BPSD at 26th ECNP Congress in Barcelona
19 27 September 2013 - Invited lecture at the Karolinska Institute, Stockholm
20 23 September 2013 Neurolixis announces in-licensing of clinical phase compounds
21 10 September 2013 Parkinson's Disease Therapeutics Conference in New York City
22 03 July 2013 - The Michael J Fox Foundation awards a second research grant to Neurolixis
23 18 June 2013 - Online neuroscience webinar: novel treatments for BPSD
24 17 June 2013 - Adrian Newman-Tancredi gives presentation at Dopamine 2013 meeting
25 14 June 2013 - Adrian Newman-Tancredi awarded Higher Doctorate (D.Sc.)
26 28 March 2013 - Just published: pharmacology of the antidepressant Levomilnacipran
27 22 March 2013 - Lectures in USA on novel "biased agonist" drugs for depression
28 19 February 2013 - Lectures on Parkinson's disease and Depression
29 08 January 2013 - Watch Adrian's ECNP lecture on webcast
30 28 December 2012 - Adrian gives psychopharmacology lectures in Netherlands
31 23 November 2012 - Lectures and PhD examination at Lyon University
32 11 October 2012 - Serotonin Club elects Adrian as new European Council member
33 03 September 2012 - Adrian to present at 25th ECNP Congress in Vienna
34 01 September 2012 - Serotonin Club Poster presentation.
35 03 July 2012 - Adrian to chair a symposium at Serotonin Club meeting
36 12 June 2012 - Adrian to present at online neuroscience webinar
37 06 June 2012 - Just published: novel PET radiotracer for brain imaging of 5-HT1A receptors
38 08 May 2012 - Adrian gives lectures and acts as PhD examiner
39 23 March 2012 - Just published: novel potential antidepressant with 5-HT2C and alpha2 actions
40 07 March 2012 - Adrian to present at AFPBN meeting in Paris
41 01 February 2012 - The Michael J. Fox Foundation awards research grant to Neurolixis
42 03 January 2012 - Adrian to present at 10th Encéphale Congress in Paris
43 02 November 2011 - Adrian gives lectures on neuropharmacology
44 03 October 2011 - Just published: Review of anatomical selectivity for Parkinson's Disease therapy
45 23 August 2011 - Just published: analgesic actions of the anti-fibromyalgia drug milnacipran
46 08 July 2011 - Launch of Neurolixis Inc.: biopharmaceutical start-up company
47 14 June 2011 - Adrian to present at 24th ECNP Congress in Paris
48 26 May 2011 - Adrian to present at Mental Disorders meeting in Santander, Spain
49 21 April 2011 - Adrian's Resume online
50 18 April 2011 - Just published: Review of "biased agonism" at 5-HT1A receptors
51 15 March 2011 - Adrian gives seminar at brain imaging center
52 14 March 2011 - Just published: Review of antipsychotics pharmacology
53 11 February 2011 - "Search" function now available on NeuroAct Communication website
54 27 January 2011 - ECNP awards Adrian fast-track society membership
55 10 December 2010 - Adrian gives lectures at academic institutions
56 19 November 2010 - Consulting assignments completed
57 15 September 2010 - Watch Adrian's ECNP lecture on webcast
58 06 August 2010 - Just published: Central 5-HT2B antagonists control dopamine release
59 03 August 2010 - Adrian to present at ECNP in Amsterdam
60 01 July 2010 - Just published: Review of 5-HT1A action of antipsychotics
61 14 June 2010 - NeuroAct Communication is now online
62 5 June 2010 - Adrian to speak at Poznan ECNP
63 25 May 2010 - Just published: articles on a new-generation 5-HT1A agonist